List of Tables
TABLE 1. CARDIAC POINT OF CARE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY CARDIAC TROPONINS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY CARDIAC TROPONINS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY CK-MB FRACTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY CK-MB FRACTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY D-DIMER, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY D-DIMER, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HEART-TYPE FATTY ACID-BINDING PROTEIN (H-FABP), BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HEART-TYPE FATTY ACID-BINDING PROTEIN (H-FABP), BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HOMOCYSTEINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HOMOCYSTEINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HS C-REACTIVE PROTEIN (CRP), BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HS C-REACTIVE PROTEIN (CRP), BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY ISCHEMIA-MODIFIED ALBUMIN (IMA), BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY ISCHEMIA-MODIFIED ALBUMIN (IMA), BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY MYOGLOBIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY ATRIAL NATRIURETIC PEPTIDE (ANP), BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY ATRIAL NATRIURETIC PEPTIDE (ANP), BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE (BNP), BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE (BNP), BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY N-TERMINAL PROBNP (NT-PROBNP), BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY N-TERMINAL PROBNP (NT-PROBNP), BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY SCD40L, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY SCD40L, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 58. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 59. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 76. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 77. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 80. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 81. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 82. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 83. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 84. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 85. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. CANADA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 90. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 91. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 92. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 93. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 94. MEXICO CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 115. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 116. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 117. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 118. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 119. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 120. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 121. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. AUSTRALIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 124. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 125. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 126. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 127. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 128. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 129. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. CHINA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 134. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 135. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 136. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 137. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 138. INDIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 139. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 140. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 141. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 142. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 143. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 144. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 145. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. INDONESIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 150. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 151. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 152. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 153. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. JAPAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 158. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 159. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 160. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 161. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 162. MALAYSIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 163. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 166. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 167. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 168. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 169. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 170. PHILIPPINES CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 171. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 174. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 175. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 176. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 177. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 178. SINGAPORE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 179. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 180. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 181. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 182. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 183. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 184. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 185. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. SOUTH KOREA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 190. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 191. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 192. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 193. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 194. TAIWAN CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 195. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 196. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 197. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 198. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 199. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 200. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 201. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. THAILAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 206. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 207. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 208. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 209. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. VIETNAM CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 221. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 224. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 225. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 226. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 227. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. DENMARK CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 232. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 233. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 234. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 235. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 236. EGYPT CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 237. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 238. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 239. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 240. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 241. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 242. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 243. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 244. FINLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 245. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 246. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 247. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 248. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 249. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 250. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 251. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. FRANCE CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 256. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 257. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 258. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 259. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 260. GERMANY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 261. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 262. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 263. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 264. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 265. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 266. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 267. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. ISRAEL CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 270. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 271. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 272. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 273. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 274. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 275. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 276. ITALY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 277. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 280. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 281. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 282. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 283. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 284. NETHERLANDS CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 285. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 286. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 287. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 288. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 289. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 290. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 291. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 292. NIGERIA CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 293. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 294. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 295. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 296. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 297. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 298. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (USD MILLION)
TABLE 299. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 300. NORWAY CARDIAC POINT OF CARE TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 301. POLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 302. POLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 303. POLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2018-2023 (USD MILLION)
TABLE 304. POLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY BIOMARKER TYPE, 2024-2030 (USD MILLION)
TABLE 305. POLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2018-2023 (USD MILLION)
TABLE 306. POLAND CARDIAC POINT OF CARE TESTING MARKET SIZE, BY NATRIURETIC PEPTIDES (NPS), 2024-2030 (U